[1]
F. Tahoori and Z. Salehi-Najafabadi, “The Ends of Lecirelin on the Destruction of Ovarian Cancer Cells”, Int Pharm Acta, vol. 7, no. 1, pp. e5: 1–8, Nov. 2024.